Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.

Sofuoglu M, Herman AI, Mooney M, Waters AJ.

Psychopharmacology (Berl). 2009 Nov;207(1):153-62. doi: 10.1007/s00213-009-1643-z. Epub 2009 Aug 20.

2.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
4.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
5.

Varenicline: for smoking cessation.

Rao J, Shankar PK.

Kathmandu Univ Med J (KUMJ). 2009 Apr-Jun;7(26):162-4. Review.

PMID:
20071853
6.

[On oral medications, especially varenicline].

Kurioka N.

Nihon Rinsho. 2013 Mar;71(3):487-92. Review. Japanese.

PMID:
23631241
7.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
8.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
9.
10.

Varenicline in smoking cessation.

Tonstad S, Rollema H.

Expert Rev Respir Med. 2010 Jun;4(3):291-9. doi: 10.1586/ers.10.27. Review.

PMID:
20524911
11.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
12.

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

Eisenberg MJ, Filion KB, Yavin D, Bélisle P, Mottillo S, Joseph L, Gervais A, O'Loughlin J, Paradis G, Rinfret S, Pilote L.

CMAJ. 2008 Jul 15;179(2):135-44. doi: 10.1503/cmaj.070256. Review. Erratum in: CMAJ. 2008 Oct 7;179(8):802.

13.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
14.

Varenicline: new treatment with efficacy in smoking cessation.

Reus VI, Obach RS, Coe JW, Faessel H, Rollema H, Watsky E, Reeves K.

Drugs Today (Barc). 2007 Feb;43(2):65-75. Review.

PMID:
17353944
15.

Varenicline: a novel pharmacotherapy for smoking cessation.

Jiménez-Ruiz C, Berlin I, Hering T.

Drugs. 2009 Jul 9;69(10):1319-38. doi: 10.2165/00003495-200969100-00003. Review.

PMID:
19583451
16.

The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.

Foulds J.

Int J Clin Pract. 2006 May;60(5):571-6. Review.

PMID:
16700857
17.
18.

Varenicline in the treatment of alcohol use disorders.

Erwin BL, Slaton RM.

Ann Pharmacother. 2014 Nov;48(11):1445-55. doi: 10.1177/1060028014545806. Epub 2014 Aug 5. Review.

PMID:
25095786
19.

Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.

Benowitz NL.

Annu Rev Pharmacol Toxicol. 2009;49:57-71. doi: 10.1146/annurev.pharmtox.48.113006.094742. Review.

20.

[Pharmacotherapies for nicotine dependence: review of scientific evidence. Spanish Society of Smoking Specialists: recommendations about election and individualization].

Olano Espinosa E, Minué Lorenzo C, Ayesta Ayesta FJ; Sociedad Española de Especialistas en Tabaquismo.

Med Clin (Barc). 2011 Jan 29;136(2):79-83. doi: 10.1016/j.medcli.2010.05.017. Review. Spanish. No abstract available.

PMID:
20884035
Items per page

Supplemental Content

Write to the Help Desk